Jeffrey Finer
InvestorVenture Partner at Third Rock Ventures
West Coast
Writes $100K – $5M checks · typically $1.5M
About
Jeffrey Finer is a physician-scientist who joined Third Rock Ventures as a Venture Partner in 2016, where he focuses on drug discovery and development opportunities across the firm's portfolio. He brings roughly 30 years of research and clinical experience, including 18 years leading drug discovery programs, preclinical development, and translational medicine efforts, and has moved several first-in-class drugs into the clinic. He has developed technology platforms integrating science, instruments, and informatics, holds several patents, and has published widely in peer-reviewed journals. He earned his M.D. and Ph.D. in Biochemistry from Stanford and B.S. degrees in Chemistry and Biology from MIT.
Beyond investing
- Education
- Holds B.S. degrees in Chemistry and Biology from the Massachusetts Institute of Technology. Earned his M.D. and Ph.D. in Biochemistry from Stanford University School of Medicine. Completed residency training in Internal Medicine at Stanford. Completed residency training in Ophthalmology at Massachusetts Eye & Ear Infirmary and Harvard Medical School.
- Awards
- Holds several patents and has published extensively in peer-reviewed journals.
Mentioned above: the Massachusetts Institute of Technology mafia → · the Stanford University School of Medicine mafia →
From Jeffrey's own website — common ground for a warm intro.
Experience
- SepternaCEO and Co-Foundercurrent2019 — presentSan Francisco Bay Area
- Third Rock VenturesVenture Partnercurrent2016 — presentSan Francisco Bay Area
- Maze TherapeuticsBoard Observer2019 — 2024
- Maze TherapeuticsInterim Chief Technology Officer2016 — 2019San Francisco Bay Area
- StrateosBoard Member2019 — 2024
- StrateosBoard Chairman2019 — 2022
- Ambys MedicinesBoard Observer2019 — 2022
- Ambys MedicinesInterim Chief Technology Officer2017 — 2019San Francisco Bay Area
- TranscripticBoard Member2018 — 2019
- Theravance Biopharma, Inc.Vice President, Research Technology2014 — 2016San Francisco Bay Area
- Theravance Biopharma, Inc.Vice President, Molecular & Cellular Biology2011 — 2014San Francisco Bay Area
- Five Prime TherapeuticsVice President, Discovery2007 — 2011San Francisco Bay Area
- CytokineticsDirector, Drug Discovery Technologies1998 — 2007San Francisco Bay Area
- Massachusetts Eye and EarResident Physician & Surgeon, Ophthalmology1996 — 1998
- Stanford University School of MedicineResident Physician, Internal Medicine1995 — 1996
Skills & more
Oncology13Assay Development9Lifesciences13Molecular Biology16Drug Discovery41Biomarker Discovery20Life Sciences15Biotechnology37Validation1Technology Transfer9Drug Development25Biochemistry13
+12 more
Cell CulturePharmacologyHPLCClinical DevelopmentCancerBiopharmaceuticalsClinical ResearchBioinformaticsPharmaceutical IndustryCROImmunologyClinical TrialsFrom Jeffrey's professional profile.
Colleagues at Third Rock Ventures
Abbie Celniker
Investor at Third Rock Ventures
Adam Tebbe
Investor at Third Rock Ventures
Alan Ezekowitz
Investor at Third Rock Ventures
Alison Connors
Investor at Third Rock Ventures
Amanda Chan
Investor at Third Rock Ventures
Andrea van Elsas
Investor at Third Rock Ventures
Andrew Warren
Senior Associate at Third Rock Ventures
Angelo Severino
Investor at Third Rock Ventures
Frequently asked questions
- Who is Jeffrey Finer?
- Jeffrey Finer is a physician-scientist who joined Third Rock Ventures as a Venture Partner in 2016, where he focuses on drug discovery and development opportunities across the firm's portfolio. He brings roughly 30 years of research and clinical experience, including 18 years leading drug discovery programs, preclinical development, and translational medicine efforts, and has moved several first-in-class drugs into the clinic. He has developed technology platforms integrating science, instruments, and informatics, holds several patents, and has published widely in peer-reviewed journals. He earned his M.D. and Ph.D. in Biochemistry from Stanford and B.S. degrees in Chemistry and Biology from MIT.
- Where does Jeffrey Finer work?
- Jeffrey Finer is Venture Partner at Third Rock Ventures.
- What check size does Jeffrey Finer write?
- Jeffrey Finer typically writes checks of $100K – $5M.
- Where did Jeffrey Finer go to school?
- Jeffrey Finer studied at Stanford University School of Medicine (MD PhD, Biophysics); Massachusetts Institute of Technology (BS, Chemistry).
- What awards has Jeffrey Finer received?
- Holds several patents and has published extensively in peer-reviewed journals.
Founder mafias
Massachusetts Institute of Technology mafia546
Also came through, then founded or led a company.
Elad GilPhDFounded Brain Co.Nat FriedmanBachelor of ScienceFounded XamarinMatt HuangB.S.Founded HotspotsDelian AsparouhovDropoutFounded Nightingale +1Drew HoustonBSFounded Dropbox +1Arash FerdowsiComputer ScienceFounded Dropbox
+ 539 more
Stanford University School of Medicine mafia20
Also came through, then founded or led a company.
Ansuman SatpathyMedical ResidentFounded Santa Ana Bio +2George FavvasCertificateFounded Clara +2Andy BeckResidency and FellowshipFounded PathaiCain McClaryResidencyFounded KDT VenturesNaveen YalamanchiMDFounded Rocket PharmaJimmy QianDropped out of M.D. program to start OsmindFounded Osmind
+ 13 more
Third Rock Ventures mafia16
Also came through, then founded or led a company.
Reid HuberPartnerFounded MOMA Therapeutics +2Christoph LengauerPartnerFounded Celsius Therapeutics +2Steve PaulVenture PartnerFounded Voyager Therapeutics, Inc. +1Alexis BorisyPartnerFounded Foundation Medicine +1Philip ReillyVenture PartnerFounded Luna Genetics +1Abbie CelnikerPartnerFounded Eleven Biotherapeutics
+ 9 more
Maze Therapeutics mafia3
Also came through, then founded or led a company.
Strateos mafia3
Also came through, then founded or led a company.
Same school
Also attended Stanford University School of Medicine83
Rebecca MancusiInvestor at Third Rock VenturesSebastian CaliriInvestment Team at 8VCAlex MorganInvestor at Khosla VenturesLauren PopovAssociate at Westlake Village BioPartnersClare OzawaManaging Director at Versant VenturesLily SarafanInvestor at Streamlined Ventures
+ 77 more
Also attended Massachusetts Institute of Technology1,387
Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDGBrad FeldCo-founder of Foundry and Techstars
+ 1,381 more
